Hospital & Healthcare Compensation Service (HCS) announced the 2022‑2023 Home Care and Hospice Salary & Benefits studies are now underway. The studies are published by HCS in cooperation with the National Association for Home Care & Hospice (NAHC).
The Reports are recognized as the authoritative source for comprehensive marketplace data for home health + hospice agencies. Last year’s Home Care Report contained data from 1,011 home health agencies. The Hospice Report had data from 734 hospice agencies.
New to both studies–Questions on staffing issues, nursing vacancy + turnover rates, and how sign-on bonuses are being used by agencies to attract new employees. The results cover job data by salary, hourly, and per visit rates with job data breakouts by auspice, revenue size, region, state, and CBSA. Regional data for 21 fringe benefits, planned salary increases, productivity, caseload, and shift differential data are also covered.
Directions to Participate in the HCS Home Care or Hospice Salary & Benefits Study:
- Download the questionnaire from the HCS website: https://www.hhcsinc.com
- Select either the single site or multi-site questionnaire for the Home Care or Hospice study
- Email Rosanne Zabka, HCS, RZabka@hhcsinc.com to confirm your planned participation
- Email your completed questionnaire to HCS by August 8th
There is no cost to participate. Participants save over 50% off the Report price.
|Participant Pricing||Home Care||Hospice|
|Prepaid Price (due by 8/31/21)||$185||$160|
As always, all individual data will be kept strictly confidential. Study results are reported as aggregated percentiles per job–No information will be released to any person or organization which will identify individual participants.
The Home Care results cover marketplace data for 59 jobs; the Hospice results cover 62 jobs. The 32nd annual Home Care Report will be published in October; the 31st annual Hospice Report will be published in November. HCS, founded in 1971, is recognized as the leader in national healthcare salary and benefits research.